Friday, November 20, 2026 · Daily editionET --:--:--

Medical

Capstan Medical said a surgeon in Chile had completed the first successful catheter-delivered mitral valve replacements in two patients using its implant and robotics system.

A dated step forward on the record · Company-reported

What the source says

“Capstan Medical today announced the first successful transcatheter mitral valve replacements using its novel implant and surgical robotics system.”
MassDevice, 6 Mar 2025

What it means

The company's claim, with no independent confirmation on our record, is that this was the first time a catheter-delivered mitral valve replacement used its system, in two patients in Chile. It is a first-in-human step, so it fits a stage short of paid use. The next entry came in November 2026, when the company reported a first U.S. case. That moved Compass to Pilot. The company also said then that it planned a pivotal trial in 2026.

Compass robotic system, from Capstan Medical, is at stage 3 of 5 on our ladder: pilot. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.

Human help: A surgeon in the operating room controls it; it doesn't operate on its own.

Written with AI from our record of Compass robotic system and checked against it: every figure appears in that record.